ASSESSMENT OF THE EFFECTIVENESS OF WORLD HEALTH ORGANIZATION STANDARD TREATMENT PROTOCOL FOR LEPROSY REACTIONS IN HO CHI MINH CITY

Đăng Trọng Tường Phan1, Hồng Hà Nguyễn2, Thế Trung Văn3,
1 Ho Chi Minh City Dermatology Hospital
2 Can Tho University of Medicine - Pharmacy
3 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: Leprosy reactions is one of the main causes of impaired motor function, sensory disturbances, and autonomic nervous system disorders. Objectives: assess the effectiveness of the WHO standard treatment protocol for reactional leprosy in Ho Chi Minh City over the period from 30/06/2006 to 30/06/2016. Materials and Methods: A series of cases were studied among patients with leprosy reactions managed in Ho Chi Minh City. Results: Treatment response evaluation based on the sensory test showed that 38.3% of patients did not respond to treatment, 10.5% had a complete response, and 48.8% were classified as normal. Evaluation of treatment response based on disability grading revealed that 32.6% of patients did not respond to treatment, 8.1% had an incomplete response, 10.5% had a complete response, and 48.8% were considered normal. Only the average number of treatment weeks showed a statistically significant difference in response evaluation based on disability grading. Conclusions: The proportion of patients who did not respond to treatment according to the WHO standard protocol was relatively high. Further expanded research with a larger number of patients is needed to clarify the findings of this study.

Article Details

References

Lambert, SM; (2014) Assessing Ciclosporin in the Treatment of Leprosy Reactions: Evidence from a Randomized Controlled Trial and Other Studies. PhD thesis, London School of Hygiene & Tropical Medicine. DOI: https://doi.org/10.17037/PUBS.02021053
2. Naafs B (2006) Treatment of Leprosy: science or politics? Trop Med Int Health 11: 268–278 doi:10.1111/j.1365-3156.2006.01561.x.
3. WHO (2020), “Leprosy/Hansen Disease: Management of reactions and prevention of disabilities”. Technical guidance.
4. Bilik L, Demir B and Cicek D (2019) Leprosy Reactions. Hansen’s Disease - The Forgotten and Neglected Disease. IntechOpen. DOI: 10.5772/intechopen.72481.
5. Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D, Lockwood DN. Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal. PLoS Negl Trop Dis. 2013;7(3):e2089. doi: 10.1371/journal.pntd.0002089.
6. Lambert SM, Nigusse SD, Alembo DT, Walker SL, Nicholls PG, Idriss MH, Yamuah LK, Lockwood DN. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia. PLoS Negl Trop Dis. 2016 Feb 26;10(2):e0004149. doi: 10.1371/journal.pntd.0004149.
7. Mittal A, Singh Dhanota DP, Saggar K, Ahluwalia A. Brachial plexopathy with ulnar nerve abscess in leprosy: A case showing importance of magnetic resonance neurography with clinical, imaging and histopathological correlation. Indian J Dermatol Venereol Leprol, 2022;88:385-8.